Published by Josh White on 22nd August 2022
(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of CYP2C19 genotype testing for clopidogrel treatment, via a new NICE diagnostics assessment programme (DAP).
URL: http://www.digitallook.com/dl/news/story/32907375/...